VDTI Vitalcare Diabetes Treatment Centers, Inc. featured news, full reports, and detailed charts
Vitalcare Diabetes Treatment Centers, Inc. (VDTI/VDTI.PK) Wrap Up:
Diversified Acquisitions, Inc. provides business processing and alternatives in the form of universal life, term life, fixed, and equity indexed annuities. The company was formerly known as Tailor Aquaponics Worldwide, Inc. and changed its name to Diversified Acquisitions, Inc. in August 2007. Diversified Acquisitions is based in Las Vegas, Nevada.Vitalcare Diabetes Treatment Centers, Inc. (VDTI:OTC)
|
Market Cap
132.7K
|
Total Revenue
19.3M
|
|
|
EBITDA
--
|
DILUTED EPS TTM
--
|
|
|
P/E
--
|
P/S
--
|
|
|
Return On Asset
-22.27
|
Return On Equity
634.83
|
|
| K = Thousands M = Millions B = Billions | ||
VDTI Top Compensated Officers
Executives, Board Directors
Key developments for Vitalcare Diabetes Treatment Centers, Inc. (VDTI)
Vitalcare Diabetes Treatment Centers Inc. announced they have two additional locations now signed under a Letter Of Intent in the state of Indiana. The centers will administering the FDA approved iCAT Treatment for diabetes related wound care for Type 1 and Type 2 diabetes patients. This is in addition to a previously announced LOI for the first center to be opened in Indiana by VitalCare.
VitalCare Diabetes Treatment Centers Inc. announced they have signed a letter of intent to establish a joint-venture relationship with South Valley Inpulse Center, LLC. The center will be administering the FDA approved iCAT treatment for Type 1 and Type 2 diabetes patients.
VitalCare Diabetes Treatment Centers Inc. announced the national launch for opening licensed diabetes treatment centers utilizing the micro-dose intravenous insulin pump technology together with proprietary algorithms and clinical protocols for providing Intercellular Activation Therapy (iCAT) for treating diabetes. The iCAT treatment is currently being administered at several clinics in Arizona, Nevada, Utah, Florida, Texas and Puerto Rico, to those who suffer from Type 1 and Type 2 Diabetes, in addition to secondary complications of Type 2 Diabetes including hypertension, peripheral vascular disease, retinopathy, heart disease, peripheral neuropathy, kidney disease, and diabetic wounds.
VDTI Competitors
| Company | Last | Change | |
| No competitor information is available for VDTI. | |||
| Market data is delayed at least 20 minutes. | |||
Industry Analysis
| Valuation | VDTI | Industry Range |
| Price/Earnings | -- | Not Meaningful |
| Price/Sales | -- | Not Meaningful |
| Price/Book | -- | Not Meaningful |
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | NM | Not Meaningful |
|
VDTI |
||
VDTI transactions
| Type Date |
Target | |
| No transactions in the last 6 months. | ||